Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 87 of the 87 references it cites were found in a registry or an index.

NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Natural History and Treatment Outcomes

Pauleikhoff, Daniel · 2005 · Retina

Abstract

In Brief Background: This review summarizes the data reported in peer-reviewed literature and presents current knowledge on differentiation, natural history, and therapeutic outcomes of neovascular age-related macular degeneration (AMD). Methods: The MEDLINE database was searched to review natural history of neovascular AMD and therapeutic effects of available treatments. Results: The search produced >7,000 articles. Research suggests that fluorescein angiographic characterization of location, composition, and size of neovascular lesions may be important in prognosis and should be considered for evaluation of treatment benefits in conjunction with evidence of recent disease progression for lesions not composed of predominantly classic choroidal neovascularization (CNV). Laser photocoagulation, photodynamic therapy with verteporfin, and administration of pegaptanib sodium reduce the risk of vision loss in selected cases of neovascular AMD, while submacular surgery can reduce the risk of severe visual acuity loss in selected cases of predominantly hemorrhagic CNV; further approaches are under investigation. Conclusion: Visual prognosis of neovascular AMD is variable according to lesion location, composition, and size. Often, lesions have a poor prognosis, resulting in rapid and progressive loss of visual acuity and contrast sensitivity. Such losses have a profound effect on patients' quality of life and ability to perform everyday tasks. Reducing the risk of further loss of visual acuity and contrast sensitivity might enable patients with neovascular AMD to maintain better functional abilities. Understanding the natural history of neovascular age-related macular degeneration and visual prognosis associated with angiographic features may help define meaningful treatment benefits. Laser photocoagulation, photodynamic therapy with verteporfin, submacular surgery, and administration of pegaptanib sodium reduce vision loss in selected cases. This review will be a useful source of information for retina specialists and general ophthalmologists.

Overview

Integrity signals

Registry

Crossref · 10.1097/00006982-200512000-00016

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 87 references

Research works printed but not linked: 9

  1. Klein, 1995, Invest Ophthalmol Vis Sci, 36, 182
  2. Thylefors, 1995, Bull World Health Organ, 73, 115
  3. Coscas, 1983, Bull Mem Soc Fr Ophtalmol, 94, 149
  4. 2001, Arch Ophthalmol, 119, 198
  5. Walsh, 1989, Ann Ophthalmol, 21, 348
  6. Stein, 2003, Br J Ophthalmol, 87, 8, 10.1136/bjo.87.1.8 · DOI
  7. Rubin, 1994, Optom Vis Sci, 71, 750, 10.1097/00006324-199412000-00005 · doi:10.1097/00006324-199412000-00005
  8. Rubin, 2001, Invest Ophthalmol Vis Sci, 42, 64
  9. 2003, Ophthalmology, 110, 2372, 10.1016/j.ophtha.2003.08.020 · DOI · Paper page

Cited by

See all 108

Metadata

Authors
Pauleikhoff, D.
Affiliations
St. Franziskus Hospital (DE)
Corresponding author
Pauleikhoff, Daniel
Venue
Retina
Published
2005-12
Volume
25
Issue
8
Pages
1065-1084
ISSN
0275-004X (ISSN-L)
OpenAlex
W2031734192
Cited by
108
References
87
Citations by year
2026: 4 · 2025: 4 · 2024: 4 · 2023: 3 · 2022: 5 · 2021: 10 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 5 · 2016: 5 · 2015: 5 · 2014: 3 · 2013: 7 · 2012: 6
FWCI
1.71
Type
journal article
Language
en
Open access
closed
Locations
  • Retina (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
Keywords
neovascular age-related macular degeneration, choroidal neovascularization, natural history (disease), visual prognosis, fluorescein angiography, laser photocoagulation, photodynamic therapy, verteporfin, pegaptanib sodium, submacular surgery, visual acuity loss, contrast sensitivity
MeSH terms
Fluorescein Angiography, Humans, Macular Degeneration, Photochemotherapy, Prognosis, Visual Acuity, Treatment Outcome, Laser Coagulation, Choroidal Neovascularization, Aptamers, Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Natural History and Treatment Outcomes. https://app.cochat.ai/papers/10.1097/00006982-200512000-00016
The paper
Pauleikhoff, D. (2005). NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Natural History and Treatment Outcomes. Retina. https://doi.org/10.1097/00006982-200512000-00016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.